This company listing is no longer activeThis company may still be operating, however this listing is no longer active. Find out why through their latest events.See Latest EventsRadient Technologies (RD8) 주식 개요Engages in the cannabinoids business in Canada. 자세히 보기RD8 펀더멘털 분석스노우플레이크 점수가치 평가2/6미래 성장0/6과거 실적0/6재무 건전성0/6배당0/6위험 분석지난 5년간 매년 수익이 2.8% 감소했습니다.마이너스 주주 지분의미 있는 시가총액이 없습니다(€2M)cash runway 경력이 1년 미만입니다.+ 위험 2건 추가모든 위험 점검 보기RD8 Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair Value€Current Price€0.000596.4% 저평가 내재 할인율Growth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture-39m13m2016201920222025202620282031Revenue CA$6.4mEarnings CA$937.8kAdvancedSet Fair ValueView all narrativesRadient Technologies Inc. 경쟁사BiofronteraSymbol: XTRA:B8FKMarket cap: €14.7mApontis PharmaSymbol: XTRA:APPHMarket cap: €91.6mSynBioticSymbol: DUSE:SBXMarket cap: €15.2mMPH Health CareSymbol: DB:93M1Market cap: €113.5m가격 이력 및 성과Radient Technologies 주가의 최고가, 최저가 및 변동 요약과거 주가현재 주가CA$0.000552주 최고가CA$0.02152주 최저가CA$0.0005베타0.881개월 변동0%3개월 변동0%1년 변동-97.56%3년 변동-99.44%5년 변동-99.95%IPO 이후 변동-99.83%최근 뉴스 및 업데이트공시 • May 18Radient Technologies Inc. Announces the Resignation of Interim Chairman Jocelyne Lafreniere from its Board of DirectorsRadient Technologies Inc. announced the resignation of interim Chairman Jocelyne Lafreniere from its board of directors, effective immediately. The board and management of the Company express their gratitude to Jocelyne for her efforts and extensive contributions, and wishes her well in her future.Reported Earnings • Dec 01Second quarter 2023 earnings released: CA$0.004 loss per share (vs CA$0.004 loss in 2Q 2022)Second quarter 2023 results: CA$0.004 loss per share (in line with 2Q 2022). Revenue: CA$1.35m (up 23% from 2Q 2022). Net loss: CA$2.35m (loss widened 43% from 2Q 2022).공시 • Oct 30Radient Technologies Inc. announced that it expects to receive CAD 1.2 million in fundingRadient Technologies Inc. (TSXV:RTI) announced a private placement of a secured promissory note for gross proceeds of up to CAD 1,200,000 on October 28, 2022. The notes carry a coupon rate of 18% per annum and outstanding principal amount of the notes as well as any accrued interest may be converted into common shares of the Company at the option of the holder at a price of CAD 0.05. The notes will mature on September 30, 2023. Securities issued under the transaction are subject to a statutory four-month hold period from the date of their issuance. Closing of the transaction remains subject to receipt of all necessary regulatory approvals, including final approval of the TSX Venture Exchange.공시 • Oct 29+ 1 more updateRadient Technologies Inc. Appoints Steven Splinter as Interim CEORadient Technologies Inc. announced the appointment of Dr. Steven Splinter as interim CEO. Dr. Steven Splinter is appointed interim CEO of Radient effective October 28, 2022. Dr. Splinter is the founder of Radient and has worked with the Company for more than 20 years, most recently in the position of Chief Technology Officer. He has been a director of the Company since 2018. Dr. Splinter's appointment follows Harry Kaura stepping down as CEO and director of the Company to pursue other business interests. Mr. Kaura has notified the Radient Board of Directors that he will continue to offerguidance and support as needed.Reported Earnings • Oct 02Full year 2022 earnings released: CA$0.029 loss per share (vs CA$0.13 loss in FY 2021)Full year 2022 results: CA$0.029 loss per share (improved from CA$0.13 loss in FY 2021). Revenue: CA$3.62m (up 46% from FY 2021). Net loss: CA$12.9m (loss narrowed 69% from FY 2021).Board Change • Sep 06Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 2 non-independent directors. Independent Chairperson of the Board Jocelyne Lafreniere was the last independent director to join the board, commencing their role in 2020. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.더 많은 업데이트 보기Recent updates공시 • May 18Radient Technologies Inc. Announces the Resignation of Interim Chairman Jocelyne Lafreniere from its Board of DirectorsRadient Technologies Inc. announced the resignation of interim Chairman Jocelyne Lafreniere from its board of directors, effective immediately. The board and management of the Company express their gratitude to Jocelyne for her efforts and extensive contributions, and wishes her well in her future.Reported Earnings • Dec 01Second quarter 2023 earnings released: CA$0.004 loss per share (vs CA$0.004 loss in 2Q 2022)Second quarter 2023 results: CA$0.004 loss per share (in line with 2Q 2022). Revenue: CA$1.35m (up 23% from 2Q 2022). Net loss: CA$2.35m (loss widened 43% from 2Q 2022).공시 • Oct 30Radient Technologies Inc. announced that it expects to receive CAD 1.2 million in fundingRadient Technologies Inc. (TSXV:RTI) announced a private placement of a secured promissory note for gross proceeds of up to CAD 1,200,000 on October 28, 2022. The notes carry a coupon rate of 18% per annum and outstanding principal amount of the notes as well as any accrued interest may be converted into common shares of the Company at the option of the holder at a price of CAD 0.05. The notes will mature on September 30, 2023. Securities issued under the transaction are subject to a statutory four-month hold period from the date of their issuance. Closing of the transaction remains subject to receipt of all necessary regulatory approvals, including final approval of the TSX Venture Exchange.공시 • Oct 29+ 1 more updateRadient Technologies Inc. Appoints Steven Splinter as Interim CEORadient Technologies Inc. announced the appointment of Dr. Steven Splinter as interim CEO. Dr. Steven Splinter is appointed interim CEO of Radient effective October 28, 2022. Dr. Splinter is the founder of Radient and has worked with the Company for more than 20 years, most recently in the position of Chief Technology Officer. He has been a director of the Company since 2018. Dr. Splinter's appointment follows Harry Kaura stepping down as CEO and director of the Company to pursue other business interests. Mr. Kaura has notified the Radient Board of Directors that he will continue to offerguidance and support as needed.Reported Earnings • Oct 02Full year 2022 earnings released: CA$0.029 loss per share (vs CA$0.13 loss in FY 2021)Full year 2022 results: CA$0.029 loss per share (improved from CA$0.13 loss in FY 2021). Revenue: CA$3.62m (up 46% from FY 2021). Net loss: CA$12.9m (loss narrowed 69% from FY 2021).Board Change • Sep 06Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 2 non-independent directors. Independent Chairperson of the Board Jocelyne Lafreniere was the last independent director to join the board, commencing their role in 2020. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.공시 • Sep 02Radient Technologies Inc. Announces Board ChangesRadient Technologies Inc. announced the appointments of Jocelyne Lafreniere, a long-time director, as the chairperson of the Board and Danesh Varma as a director of the Company. Ms. Lafreniere's appointment is effective immediately and follows the resignation of Francesco Ferlaino as a director and the chairperson of the Board. Mr. Varma's appointment will be effective upon satisfactory security clearance by Health Canada. Danesh Varma established himself in the Canadian business community as a senior audit manager with Deloitte's in Canada. In addition, he has served with reporting issuers, both as CFO and as a Director in both Canada and the United States, for companies such as Labrador Iron Mines Holdings and Brookfield Investment Corporation. Now a U.K. resident, Mr. Varma is active in the investment and private equity fields.공시 • Jun 19Radient Technologies Inc. announced that it expects to receive CAD 1.2 million in fundingRadient Technologies Inc. announced a best efforts non-brokered private placement financing of up to 30 units at a price of CAD 40,000 per unit for gross proceeds of up to CAD 1,200,000 on June 17, 2022. Each unit shall consist of 1,000,000 common shares of the company and 500,000 common share purchase warrants with each warrant entitling the holder to purchase one common share of the company at CAD 0.07 per share for 36 months following the closing of the transaction subject to early expiry if, commencing four months after the closing of the transaction, the common shares of the company trade at a volume weighted average trading price of CAD 0.15 or higher for a period of 20 consecutive days. The transaction is expected to close on June 30, 2022. Finder's fees may be paid to eligible finders in accordance with the policies of the TSX Venture Exchange. All securities issued in connection with the transaction will be subject to a statutory hold period of four months and one day. Completion of the transaction is subject to certain conditions, including TSXV approval.공시 • Apr 06Radient Technologies Inc. announced that it expects to receive CAD 9.93 million in funding from Moskowitz Capital Mortgage Fund II Inc.Radient Technologies Inc. announced that it will receive CAD 9,930,000 in a round of funding on April 4, 2022. The company will issue loans with warrants in the transaction. The transaction includes participation from Moskowitz Capital Mortgage Fund II Inc. The company will issue 10,000,000 non-transferable common share purchase warrants, each warrant entitling to purchase one common share of the company at an exercise price of CAD 0.085 for one year following the date of issuance. No finder's fees are payable in connection with the amendment. All securities issued in connection with the amendment will be subject to a statutory hold period expiring four months and one day following the issuance date of the warrants. The issuance of the warrants is subject to the approval of the TSX Venture Exchange.Reported Earnings • Mar 03Third quarter 2022 earnings: Revenues and EPS in line with analyst expectationsThird quarter 2022 results: CA$0.007 loss per share (up from CA$0.034 loss in 3Q 2021). Revenue: CA$1.58m (down 13% from 3Q 2021). Net loss: CA$3.20m (loss narrowed 72% from 3Q 2021). Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 4% per year but the company’s share price has fallen by 62% per year, which means it is significantly lagging earnings.Board Change • Feb 02Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Director Jocelyne Lafreniere was the last independent director to join the board, commencing their role in 2020. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.공시 • Jan 30Radient Technologies Inc. (TSXV:RTI) completed the acquisition of Tunaaaa Room Xtracts Inc. for $8.075 million.Radient Technologies Inc. (TSXV:RTI) entered into a binding letter of intent to acquire Tunaaaa Room Xtracts Inc. from Tunaaaa Room Inc. for $6.8 million on June 30, 2021. Under the terms of consideration Radient will issue 50 million of its common shares, at a deemed price of CAD 0.12 per share, for an aggregate deemed value of CAD 6 million; 15 million of its common share purchase warrants, with each warrant entitling the holder thereof to acquire one of Radient's common shares for CAD 0.15 for a period of 24 months following closing; 30 million common share purchase warrants, with each warrant entitling the holder thereof to acquire one common share for CAD 0.20 for a period of 24 months following the date of issuance, provided TRX achieves certain specified gross revenue milestones within 24 months following closing. Radient will also pay 2% royalty on all gross sales of TRX products. The deal is subject to consummation of due diligence, signing of definitive agreement and approval from Toronto stock exchange. The deal is expected to close in August 2021. As of October 6, 2021, the transaction is expected to close by October 30, 2021. As of November 29, 2021, Radient Technologies signed Definitive Agreement to acquire Tunaaaa Room Xtracts Inc. from Tunaaaa Room Inc. for $8.075 million. Pursuant to the Definitive Agreement, Radient will acquire Tunaaaa for 70 million common shares of Radient priced at CAD 0.12 per share and 15 million warrants of Radient exercisable at a price of CAD 0.15 per share for a period of two years following the closing of the Acquisition, and up to 25 million common shares of Radient at a deemed price of CAD 0.12 per share issued contingently upon certain revenue performance milestone achievements following the closing of the Acquisition. Radient will also pay 4% royalty on all gross sales of TRX products if the revenue is greater than $0.5 million in a month. As of November 29, 2021, the transaction is expected to close prior to December 31, 2021. As of January 6, 2022 Tunaaaa Room Inc. was replaced as a shareholder and vendor of the Target by its two shareholders. Radient Technologies Inc. (TSXV:RTI) completed the acquisition of Tunaaaa Room Xtracts Inc. on January 28, 2022. Radient will pay 1% royalty on all gross sales of TRX products.Recent Insider Transactions • Jan 15Chief Financial Officer recently bought €149k worth of stockOn the 11th of January, Prakash Hariharan bought around 4m shares on-market at roughly €0.042 per share. This was the largest purchase by an insider in the last 3 months. Prakash has been a buyer over the last 12 months, purchasing a net total of €197k worth in shares.공시 • Dec 16Radient Technologies Inc. announced that it expects to receive CAD 1.2 million in fundingRadient Technologies Inc. announced a non-brokered private placement of up to 20,000,000 units at a price of CAD 0.06 per unit for gross proceeds of up to CAD 1,200,000 on December 15, 2021. Each unit will consist of one common share of the company and one common share purchase warrant, with each warrant entitling the holder to purchase one common share of the company at CAD 0.10 per share for a period of 18 months following the closing date of the offering. The offering is expected to close on or about December 31, 2021. The company may pay finder's fees in cash of up to 7% of gross proceeds of the offering and finder's warrants in an amount of up to 7% of the units sold pursuant to the offering to eligible finders in accordance with the policies of the TSX Venture Exchange. Each finder warrant will entitle the holder thereof to purchase one common share of the company at a price of CAD 0.10 for a period of 18 months following the closing date of the offering. All securities issued by the company in connection with the offering will be subject to a statutory hold period of four months and one day. Completion of the offering is subject to certain conditions, including TSX Venture Exchange approval.Reported Earnings • Nov 30Second quarter 2022 earnings: Revenues and EPS in line with analyst expectationsSecond quarter 2022 results: CA$0.004 loss per share (up from CA$0.011 loss in 2Q 2021). Revenue: CA$1.10m (up CA$994.4k from 2Q 2021). Net loss: CA$1.64m (loss narrowed 52% from 2Q 2021). Revenue was in line with analyst estimates.Reported Earnings • Oct 03Full year 2021 earnings released: CA$0.13 loss per share (vs CA$0.14 loss in FY 2020)The company reported a poor full year result with increased losses, weaker revenues and weaker control over costs. Full year 2021 results: Revenue: CA$2.49m (down 87% from FY 2020). Net loss: CA$42.3m (loss widened 13% from FY 2020).공시 • Jul 02Radient Technologies Inc. (TSXV:RTI) entered into a binding letter of intent to acquire Tunaaaa Room Xtracts Inc. from Tunaaaa Room Inc.Radient Technologies Inc. (TSXV:RTI) entered into a binding letter of intent to acquire Tunaaaa Room Xtracts Inc. from Tunaaaa Room Inc. on June 30, 2021. Under the terms of consideration Radient will issue 50 million of its common shares, at a deemed price of $0.12 per share, for an aggregate deemed value of $6 million;15 million of its common share purchase warrants, with each warrant entitling the holder thereof to acquire one of Radient's common shares (each, a "Common Share") for $0.15 for a period of 24 months following Closing; 30 million Common Share purchase warrants, with each warrant entitling the holder thereof to acquire one Common Share for $0.20 for a period of 24 months following the date of issuance, provided TRX achieves certain specified gross revenue milestones within 24 months following Closing. Radient will also pay 2% of all gross sales of TRX products. The executive team of Tunaaaa Room shall be required to work for the benefit of Radient to develop new terpene blends and launch new products and brands, and provide exclusive cannabis-growing management services to Radient. The deal is subject to consummation of due diligence, signing of definitive agreement and approval from Toronto stock exchange. The deal is expected to close in August 2021.공시 • Mar 17Radient Technologies Inc. announced that it has received CAD 2.9955 million in fundingOn March 15, 2021, Radient Technologies Inc. (TSXV:RTI) closed the transaction. The company issued 13,425,000 shares for gross proceeds of CAD 13,425,000 in its third and final tranche. The company has raised CAD 2,995,500 in funding so far in the transaction. The transaction included participation from 40 placees including Steven Splinter for 250,000 shares, Yves Gougoux for 500,000 shares, Jan Pretzel for 500,000 shares, Jocelyne Lafreniere for 500,000 shares, Francesco Ferlaino for 750,000 shares, and Prakash Hariharan for 650,000 shares. The company paid a finders' fees of CAD 175,190 with respect to the transaction, CAD 102,600 to Michael Sobolewski, CAD 49,840 to HB Investments & Finance AG, and CAD 22,750 to Cannacord Genuity Corp.Reported Earnings • Mar 02Third quarter 2021 earnings released: CA$0.034 loss per share (vs CA$0.02 loss in 3Q 2020)The company reported a poor third quarter result with increased losses, weaker revenues and weaker control over costs. Third quarter 2021 results: Revenue: CA$1.81m (down 84% from 3Q 2020). Net loss: CA$11.2m (loss widened 106% from 3Q 2020). Over the last 3 years on average, earnings per share has fallen by 23% per year but the company’s share price has fallen by 60% per year, which means it is performing significantly worse than earnings.공시 • Feb 05Radient Technologies Inc. Announces Executive ChangesRadient Technologies Inc. announced the appointment of Harry Kaura as the CEO of the Company effective Feb. 03, 2021. Harry is an Edmonton based hands on entrepreneur, with vast experience in operations and business development through his firm Amnor Corporation. He has over three decades of experience as a hands-on operator and fully capable to lead Radient into its new path as a profitable operating business. As Harry has served as a Director in Radient's Board since 2013 and dedicated the past five months in the Business Development initiatives and the management of the operations for Radient. He led the team in Radient in the reorganization of the manufacturing unit that is in full ramp up mode since January 2021. While Jan Petzel will hand over his role as interim CEO of Radient, he will continue to serve the business in an active advisory role to in support Harry Kaura and the team. Jan has been instrumental in leading the transformation of the Company towards a path to operating profitability in calendar 2021.Reported Earnings • Dec 02Second quarter 2021 earnings released: CA$0.011 loss per shareThe company reported a soft second quarter result with weaker revenues and control over expenses, though losses reduced. Second quarter 2021 results: Revenue: CA$102.7k (down 92% from 2Q 2020). Net loss: CA$3.41m (loss narrowed 51% from 2Q 2020). Over the last 3 years on average, earnings per share has fallen by 24% per year but the company’s share price has fallen by 65% per year, which means it is performing significantly worse than earnings.공시 • Nov 28Radient Technologies Announces Receipt of Cannabis Research Licence for Human Administration Trials and Sensory and Taste Evaluation of Cannabis ProductsRadient Technologies Inc. announced that it has received its Cannabis Research Licence under Health Canada's Cannabis Act and Cannabis Regulations. This license permits Radient to expand its research activities by allowing the controlled administration of cannabis to human subjects to complete a comprehensive evaluation of sensory preferences. A human sensory panel is an extremely valuable tool to include in product development and quality programs. It will now form an integral part of Radient's R&D and product development and innovation activities by including the ability to evaluate cannabis extracts, concentrates, edibles and topicals for reactions of human subjects to the smell, sight, taste and touch at the product development stage. This new tool will improve the inherent quality of cannabis product offerings by complementing the stringent internal manufacturing quality systems currently in place, ensuring that all products continue to meet consumers' expectations. This is in addition to Radient's proprietary MAP continuous extraction process that has proven to generate high recoveries (> 95%) of active compounds from the cannabis plant.공시 • Nov 26Radient Technologies Announces Partnership with Dreamy CBDRadient Technologies Inc. announced a licensing agreement with Dreamy Co., (“Dreamy”) to bring in Dreamy CBD products under Radient’s platform to Canada and extend it to other international markets. Initially founded in the US, Dreamy has developed a lifestyle brand over the past decade focused on the Health and Wellness space before branching into the CBD vertical. Dreamy is focused on creating and inspiring people to use plant medicine and holistic healing in place of conventional pharmaceutical solutions. In the US, Dreamy CBD enjoys a strong presence in California, and the Dreamy brand has a strong association with a positive lifestyle in the rapidly growing Wellness space. The Dreamy CBD products comprise CBD tinctures, CBD distillates, CBD edibles, CBD cosmetics, and CBD Vape Cartridges geared towards the recreational and medical cannabis market. Under this partnership, Radient will have exclusive rights to the licenses and trademarks for Dreamy CBD brands and will collaborate jointly with Dreamy to produce their CBD products and launch their brands in Canada. Radient will be involved in providing the processing facilities in Edmonton and the necessary infrastructure to extract CBD products for Dreamy CBD. In addition, through its Sales License and associated registrations in the provinces, Radient will look to build the Dreamy CBD product portfolio in Canada. On the international front, Radient will produce their CBD based products for markets in Thailand and Japan that are witnessing a strong surge in CBD products consumption, especially in the Wellness space. This will be after completing a comprehensive review of the trade requirements with local partners in these jurisdictions. The partnership is being set initially for a two-year term with an annual renewable option, with Radient reserving the right of first refusal to acquire Dreamy.Reported Earnings • Oct 10First quarter earnings releasedOver the last 12 months the company has reported total losses of CA$36.5m, with losses widening by 19% from the prior year. Total revenue was CA$18.4m over the last 12 months, up by CA$18.2m from the prior year.공시 • Sep 19+ 1 more updateRadient Technologies Inc. Announces Management ChangesThe board of Radient Technologies Inc. named Jan Petzel as Interim President, effective immediately. Mr. Petzel has been a Director of the Radient since 2016 and has a comprehensive understanding of the company, and a pragmatic view of the priorities that need to be addressed. Jan was a managing director in the Merchant Banking Division of Goldman Sachs, ultimately responsible for private credit in Germany and Scandinavia. While at Goldman Sachs, Mr. Petzel served on the board of several successful companies including Cognis GmbH, a worldwide supplier of specialty chemicals and nutritional ingredients, up to its sale to BASF for €3.1 billion in 2010. The company also announced that Denis Taschuk will step down as president and director of the company, effectively immediately, for family reasons. He will continue as advisor to the Board to facilitate the transition to a new chief executive officer. Denis has been instrumental in leading Radient to become a significant company in the cannabis industry, and the Board wishes to thank Denis for his contribution and tireless efforts over the last 10 years. The company also announced that Mike Cabigon will step down as chief operating officer and director of the company, effective immediately, to pursue other interests. Mike was instrumental in the company’s pivot into the cannabis industry in 2016, and the Board thanks him for all his contribution over the years and wishes him well in his future endeavors.공시 • Sep 17Radient Technologies Inc. Auditor Raises 'Going Concern' DoubtRadient Technologies Inc. filed its Annual on Sep 14, 2020 for the period ending Mar 31, 2020. In this report its auditor, Grant Thornton, gave an unqualified opinion expressing doubt that the company can continue as a going concern.주주 수익률RD8DE PharmaceuticalsDE 시장7D0%3.4%0.6%1Y-97.6%26.6%0.2%전체 주주 수익률 보기수익률 대 산업: RD8은 지난 1년 동안 26.6%의 수익을 기록한 German Pharmaceuticals 산업보다 저조한 성과를 냈습니다.수익률 대 시장: RD8은 지난 1년 동안 0.2%를 기록한 German 시장보다 저조한 성과를 냈습니다.주가 변동성Is RD8's price volatile compared to industry and market?RD8 volatilityRD8 Average Weekly Movementn/aPharmaceuticals Industry Average Movement6.3%Market Average Movement6.1%10% most volatile stocks in DE Market13.2%10% least volatile stocks in DE Market2.7%안정적인 주가: RD8의 주가는 지난 3개월 동안 German 시장보다 변동성이 컸습니다.시간에 따른 변동성: Insufficient data to determine RD8의 변동성 변화를 판단할 수 없습니다.회사 소개설립직원 수CEO웹사이트n/an/aSteven Splinterwww.radientinc.com더 보기Radient Technologies Inc. 기초 지표 요약Radient Technologies의 순이익과 매출은 시가총액과 어떻게 비교됩니까?RD8 기초 통계시가총액€1.88m순이익 (TTM)-€7.86m매출 (TTM)€2.19m0.9x주가매출비율(P/S)-0.2x주가수익비율(P/E)RD8는 고평가되어 있습니까?공정 가치 및 평가 분석 보기순이익 및 매출최근 실적 보고서(TTM)의 주요 수익성 지표RD8 손익계산서 (TTM)매출CA$3.15m매출원가CA$3.87m총이익-CA$718.42k기타 비용CA$10.58m순이익-CA$11.30m최근 보고된 실적Dec 31, 2022다음 실적 발표일해당 없음주당순이익(EPS)-0.021총이익률-22.82%순이익률-359.00%부채/자본 비율-80.4%RD8의 장기 실적은 어땠습니까?과거 실적 및 비교 보기View Valuation기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2023/06/05 20:20종가2023/03/08 00:00수익2022/12/31연간 수익2022/03/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Radient Technologies Inc.는 0명의 분석가가 다루고 있습니다. 이 중 명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
공시 • May 18Radient Technologies Inc. Announces the Resignation of Interim Chairman Jocelyne Lafreniere from its Board of DirectorsRadient Technologies Inc. announced the resignation of interim Chairman Jocelyne Lafreniere from its board of directors, effective immediately. The board and management of the Company express their gratitude to Jocelyne for her efforts and extensive contributions, and wishes her well in her future.
Reported Earnings • Dec 01Second quarter 2023 earnings released: CA$0.004 loss per share (vs CA$0.004 loss in 2Q 2022)Second quarter 2023 results: CA$0.004 loss per share (in line with 2Q 2022). Revenue: CA$1.35m (up 23% from 2Q 2022). Net loss: CA$2.35m (loss widened 43% from 2Q 2022).
공시 • Oct 30Radient Technologies Inc. announced that it expects to receive CAD 1.2 million in fundingRadient Technologies Inc. (TSXV:RTI) announced a private placement of a secured promissory note for gross proceeds of up to CAD 1,200,000 on October 28, 2022. The notes carry a coupon rate of 18% per annum and outstanding principal amount of the notes as well as any accrued interest may be converted into common shares of the Company at the option of the holder at a price of CAD 0.05. The notes will mature on September 30, 2023. Securities issued under the transaction are subject to a statutory four-month hold period from the date of their issuance. Closing of the transaction remains subject to receipt of all necessary regulatory approvals, including final approval of the TSX Venture Exchange.
공시 • Oct 29+ 1 more updateRadient Technologies Inc. Appoints Steven Splinter as Interim CEORadient Technologies Inc. announced the appointment of Dr. Steven Splinter as interim CEO. Dr. Steven Splinter is appointed interim CEO of Radient effective October 28, 2022. Dr. Splinter is the founder of Radient and has worked with the Company for more than 20 years, most recently in the position of Chief Technology Officer. He has been a director of the Company since 2018. Dr. Splinter's appointment follows Harry Kaura stepping down as CEO and director of the Company to pursue other business interests. Mr. Kaura has notified the Radient Board of Directors that he will continue to offerguidance and support as needed.
Reported Earnings • Oct 02Full year 2022 earnings released: CA$0.029 loss per share (vs CA$0.13 loss in FY 2021)Full year 2022 results: CA$0.029 loss per share (improved from CA$0.13 loss in FY 2021). Revenue: CA$3.62m (up 46% from FY 2021). Net loss: CA$12.9m (loss narrowed 69% from FY 2021).
Board Change • Sep 06Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 2 non-independent directors. Independent Chairperson of the Board Jocelyne Lafreniere was the last independent director to join the board, commencing their role in 2020. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
공시 • May 18Radient Technologies Inc. Announces the Resignation of Interim Chairman Jocelyne Lafreniere from its Board of DirectorsRadient Technologies Inc. announced the resignation of interim Chairman Jocelyne Lafreniere from its board of directors, effective immediately. The board and management of the Company express their gratitude to Jocelyne for her efforts and extensive contributions, and wishes her well in her future.
Reported Earnings • Dec 01Second quarter 2023 earnings released: CA$0.004 loss per share (vs CA$0.004 loss in 2Q 2022)Second quarter 2023 results: CA$0.004 loss per share (in line with 2Q 2022). Revenue: CA$1.35m (up 23% from 2Q 2022). Net loss: CA$2.35m (loss widened 43% from 2Q 2022).
공시 • Oct 30Radient Technologies Inc. announced that it expects to receive CAD 1.2 million in fundingRadient Technologies Inc. (TSXV:RTI) announced a private placement of a secured promissory note for gross proceeds of up to CAD 1,200,000 on October 28, 2022. The notes carry a coupon rate of 18% per annum and outstanding principal amount of the notes as well as any accrued interest may be converted into common shares of the Company at the option of the holder at a price of CAD 0.05. The notes will mature on September 30, 2023. Securities issued under the transaction are subject to a statutory four-month hold period from the date of their issuance. Closing of the transaction remains subject to receipt of all necessary regulatory approvals, including final approval of the TSX Venture Exchange.
공시 • Oct 29+ 1 more updateRadient Technologies Inc. Appoints Steven Splinter as Interim CEORadient Technologies Inc. announced the appointment of Dr. Steven Splinter as interim CEO. Dr. Steven Splinter is appointed interim CEO of Radient effective October 28, 2022. Dr. Splinter is the founder of Radient and has worked with the Company for more than 20 years, most recently in the position of Chief Technology Officer. He has been a director of the Company since 2018. Dr. Splinter's appointment follows Harry Kaura stepping down as CEO and director of the Company to pursue other business interests. Mr. Kaura has notified the Radient Board of Directors that he will continue to offerguidance and support as needed.
Reported Earnings • Oct 02Full year 2022 earnings released: CA$0.029 loss per share (vs CA$0.13 loss in FY 2021)Full year 2022 results: CA$0.029 loss per share (improved from CA$0.13 loss in FY 2021). Revenue: CA$3.62m (up 46% from FY 2021). Net loss: CA$12.9m (loss narrowed 69% from FY 2021).
Board Change • Sep 06Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 2 non-independent directors. Independent Chairperson of the Board Jocelyne Lafreniere was the last independent director to join the board, commencing their role in 2020. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
공시 • Sep 02Radient Technologies Inc. Announces Board ChangesRadient Technologies Inc. announced the appointments of Jocelyne Lafreniere, a long-time director, as the chairperson of the Board and Danesh Varma as a director of the Company. Ms. Lafreniere's appointment is effective immediately and follows the resignation of Francesco Ferlaino as a director and the chairperson of the Board. Mr. Varma's appointment will be effective upon satisfactory security clearance by Health Canada. Danesh Varma established himself in the Canadian business community as a senior audit manager with Deloitte's in Canada. In addition, he has served with reporting issuers, both as CFO and as a Director in both Canada and the United States, for companies such as Labrador Iron Mines Holdings and Brookfield Investment Corporation. Now a U.K. resident, Mr. Varma is active in the investment and private equity fields.
공시 • Jun 19Radient Technologies Inc. announced that it expects to receive CAD 1.2 million in fundingRadient Technologies Inc. announced a best efforts non-brokered private placement financing of up to 30 units at a price of CAD 40,000 per unit for gross proceeds of up to CAD 1,200,000 on June 17, 2022. Each unit shall consist of 1,000,000 common shares of the company and 500,000 common share purchase warrants with each warrant entitling the holder to purchase one common share of the company at CAD 0.07 per share for 36 months following the closing of the transaction subject to early expiry if, commencing four months after the closing of the transaction, the common shares of the company trade at a volume weighted average trading price of CAD 0.15 or higher for a period of 20 consecutive days. The transaction is expected to close on June 30, 2022. Finder's fees may be paid to eligible finders in accordance with the policies of the TSX Venture Exchange. All securities issued in connection with the transaction will be subject to a statutory hold period of four months and one day. Completion of the transaction is subject to certain conditions, including TSXV approval.
공시 • Apr 06Radient Technologies Inc. announced that it expects to receive CAD 9.93 million in funding from Moskowitz Capital Mortgage Fund II Inc.Radient Technologies Inc. announced that it will receive CAD 9,930,000 in a round of funding on April 4, 2022. The company will issue loans with warrants in the transaction. The transaction includes participation from Moskowitz Capital Mortgage Fund II Inc. The company will issue 10,000,000 non-transferable common share purchase warrants, each warrant entitling to purchase one common share of the company at an exercise price of CAD 0.085 for one year following the date of issuance. No finder's fees are payable in connection with the amendment. All securities issued in connection with the amendment will be subject to a statutory hold period expiring four months and one day following the issuance date of the warrants. The issuance of the warrants is subject to the approval of the TSX Venture Exchange.
Reported Earnings • Mar 03Third quarter 2022 earnings: Revenues and EPS in line with analyst expectationsThird quarter 2022 results: CA$0.007 loss per share (up from CA$0.034 loss in 3Q 2021). Revenue: CA$1.58m (down 13% from 3Q 2021). Net loss: CA$3.20m (loss narrowed 72% from 3Q 2021). Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 4% per year but the company’s share price has fallen by 62% per year, which means it is significantly lagging earnings.
Board Change • Feb 02Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Director Jocelyne Lafreniere was the last independent director to join the board, commencing their role in 2020. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
공시 • Jan 30Radient Technologies Inc. (TSXV:RTI) completed the acquisition of Tunaaaa Room Xtracts Inc. for $8.075 million.Radient Technologies Inc. (TSXV:RTI) entered into a binding letter of intent to acquire Tunaaaa Room Xtracts Inc. from Tunaaaa Room Inc. for $6.8 million on June 30, 2021. Under the terms of consideration Radient will issue 50 million of its common shares, at a deemed price of CAD 0.12 per share, for an aggregate deemed value of CAD 6 million; 15 million of its common share purchase warrants, with each warrant entitling the holder thereof to acquire one of Radient's common shares for CAD 0.15 for a period of 24 months following closing; 30 million common share purchase warrants, with each warrant entitling the holder thereof to acquire one common share for CAD 0.20 for a period of 24 months following the date of issuance, provided TRX achieves certain specified gross revenue milestones within 24 months following closing. Radient will also pay 2% royalty on all gross sales of TRX products. The deal is subject to consummation of due diligence, signing of definitive agreement and approval from Toronto stock exchange. The deal is expected to close in August 2021. As of October 6, 2021, the transaction is expected to close by October 30, 2021. As of November 29, 2021, Radient Technologies signed Definitive Agreement to acquire Tunaaaa Room Xtracts Inc. from Tunaaaa Room Inc. for $8.075 million. Pursuant to the Definitive Agreement, Radient will acquire Tunaaaa for 70 million common shares of Radient priced at CAD 0.12 per share and 15 million warrants of Radient exercisable at a price of CAD 0.15 per share for a period of two years following the closing of the Acquisition, and up to 25 million common shares of Radient at a deemed price of CAD 0.12 per share issued contingently upon certain revenue performance milestone achievements following the closing of the Acquisition. Radient will also pay 4% royalty on all gross sales of TRX products if the revenue is greater than $0.5 million in a month. As of November 29, 2021, the transaction is expected to close prior to December 31, 2021. As of January 6, 2022 Tunaaaa Room Inc. was replaced as a shareholder and vendor of the Target by its two shareholders. Radient Technologies Inc. (TSXV:RTI) completed the acquisition of Tunaaaa Room Xtracts Inc. on January 28, 2022. Radient will pay 1% royalty on all gross sales of TRX products.
Recent Insider Transactions • Jan 15Chief Financial Officer recently bought €149k worth of stockOn the 11th of January, Prakash Hariharan bought around 4m shares on-market at roughly €0.042 per share. This was the largest purchase by an insider in the last 3 months. Prakash has been a buyer over the last 12 months, purchasing a net total of €197k worth in shares.
공시 • Dec 16Radient Technologies Inc. announced that it expects to receive CAD 1.2 million in fundingRadient Technologies Inc. announced a non-brokered private placement of up to 20,000,000 units at a price of CAD 0.06 per unit for gross proceeds of up to CAD 1,200,000 on December 15, 2021. Each unit will consist of one common share of the company and one common share purchase warrant, with each warrant entitling the holder to purchase one common share of the company at CAD 0.10 per share for a period of 18 months following the closing date of the offering. The offering is expected to close on or about December 31, 2021. The company may pay finder's fees in cash of up to 7% of gross proceeds of the offering and finder's warrants in an amount of up to 7% of the units sold pursuant to the offering to eligible finders in accordance with the policies of the TSX Venture Exchange. Each finder warrant will entitle the holder thereof to purchase one common share of the company at a price of CAD 0.10 for a period of 18 months following the closing date of the offering. All securities issued by the company in connection with the offering will be subject to a statutory hold period of four months and one day. Completion of the offering is subject to certain conditions, including TSX Venture Exchange approval.
Reported Earnings • Nov 30Second quarter 2022 earnings: Revenues and EPS in line with analyst expectationsSecond quarter 2022 results: CA$0.004 loss per share (up from CA$0.011 loss in 2Q 2021). Revenue: CA$1.10m (up CA$994.4k from 2Q 2021). Net loss: CA$1.64m (loss narrowed 52% from 2Q 2021). Revenue was in line with analyst estimates.
Reported Earnings • Oct 03Full year 2021 earnings released: CA$0.13 loss per share (vs CA$0.14 loss in FY 2020)The company reported a poor full year result with increased losses, weaker revenues and weaker control over costs. Full year 2021 results: Revenue: CA$2.49m (down 87% from FY 2020). Net loss: CA$42.3m (loss widened 13% from FY 2020).
공시 • Jul 02Radient Technologies Inc. (TSXV:RTI) entered into a binding letter of intent to acquire Tunaaaa Room Xtracts Inc. from Tunaaaa Room Inc.Radient Technologies Inc. (TSXV:RTI) entered into a binding letter of intent to acquire Tunaaaa Room Xtracts Inc. from Tunaaaa Room Inc. on June 30, 2021. Under the terms of consideration Radient will issue 50 million of its common shares, at a deemed price of $0.12 per share, for an aggregate deemed value of $6 million;15 million of its common share purchase warrants, with each warrant entitling the holder thereof to acquire one of Radient's common shares (each, a "Common Share") for $0.15 for a period of 24 months following Closing; 30 million Common Share purchase warrants, with each warrant entitling the holder thereof to acquire one Common Share for $0.20 for a period of 24 months following the date of issuance, provided TRX achieves certain specified gross revenue milestones within 24 months following Closing. Radient will also pay 2% of all gross sales of TRX products. The executive team of Tunaaaa Room shall be required to work for the benefit of Radient to develop new terpene blends and launch new products and brands, and provide exclusive cannabis-growing management services to Radient. The deal is subject to consummation of due diligence, signing of definitive agreement and approval from Toronto stock exchange. The deal is expected to close in August 2021.
공시 • Mar 17Radient Technologies Inc. announced that it has received CAD 2.9955 million in fundingOn March 15, 2021, Radient Technologies Inc. (TSXV:RTI) closed the transaction. The company issued 13,425,000 shares for gross proceeds of CAD 13,425,000 in its third and final tranche. The company has raised CAD 2,995,500 in funding so far in the transaction. The transaction included participation from 40 placees including Steven Splinter for 250,000 shares, Yves Gougoux for 500,000 shares, Jan Pretzel for 500,000 shares, Jocelyne Lafreniere for 500,000 shares, Francesco Ferlaino for 750,000 shares, and Prakash Hariharan for 650,000 shares. The company paid a finders' fees of CAD 175,190 with respect to the transaction, CAD 102,600 to Michael Sobolewski, CAD 49,840 to HB Investments & Finance AG, and CAD 22,750 to Cannacord Genuity Corp.
Reported Earnings • Mar 02Third quarter 2021 earnings released: CA$0.034 loss per share (vs CA$0.02 loss in 3Q 2020)The company reported a poor third quarter result with increased losses, weaker revenues and weaker control over costs. Third quarter 2021 results: Revenue: CA$1.81m (down 84% from 3Q 2020). Net loss: CA$11.2m (loss widened 106% from 3Q 2020). Over the last 3 years on average, earnings per share has fallen by 23% per year but the company’s share price has fallen by 60% per year, which means it is performing significantly worse than earnings.
공시 • Feb 05Radient Technologies Inc. Announces Executive ChangesRadient Technologies Inc. announced the appointment of Harry Kaura as the CEO of the Company effective Feb. 03, 2021. Harry is an Edmonton based hands on entrepreneur, with vast experience in operations and business development through his firm Amnor Corporation. He has over three decades of experience as a hands-on operator and fully capable to lead Radient into its new path as a profitable operating business. As Harry has served as a Director in Radient's Board since 2013 and dedicated the past five months in the Business Development initiatives and the management of the operations for Radient. He led the team in Radient in the reorganization of the manufacturing unit that is in full ramp up mode since January 2021. While Jan Petzel will hand over his role as interim CEO of Radient, he will continue to serve the business in an active advisory role to in support Harry Kaura and the team. Jan has been instrumental in leading the transformation of the Company towards a path to operating profitability in calendar 2021.
Reported Earnings • Dec 02Second quarter 2021 earnings released: CA$0.011 loss per shareThe company reported a soft second quarter result with weaker revenues and control over expenses, though losses reduced. Second quarter 2021 results: Revenue: CA$102.7k (down 92% from 2Q 2020). Net loss: CA$3.41m (loss narrowed 51% from 2Q 2020). Over the last 3 years on average, earnings per share has fallen by 24% per year but the company’s share price has fallen by 65% per year, which means it is performing significantly worse than earnings.
공시 • Nov 28Radient Technologies Announces Receipt of Cannabis Research Licence for Human Administration Trials and Sensory and Taste Evaluation of Cannabis ProductsRadient Technologies Inc. announced that it has received its Cannabis Research Licence under Health Canada's Cannabis Act and Cannabis Regulations. This license permits Radient to expand its research activities by allowing the controlled administration of cannabis to human subjects to complete a comprehensive evaluation of sensory preferences. A human sensory panel is an extremely valuable tool to include in product development and quality programs. It will now form an integral part of Radient's R&D and product development and innovation activities by including the ability to evaluate cannabis extracts, concentrates, edibles and topicals for reactions of human subjects to the smell, sight, taste and touch at the product development stage. This new tool will improve the inherent quality of cannabis product offerings by complementing the stringent internal manufacturing quality systems currently in place, ensuring that all products continue to meet consumers' expectations. This is in addition to Radient's proprietary MAP continuous extraction process that has proven to generate high recoveries (> 95%) of active compounds from the cannabis plant.
공시 • Nov 26Radient Technologies Announces Partnership with Dreamy CBDRadient Technologies Inc. announced a licensing agreement with Dreamy Co., (“Dreamy”) to bring in Dreamy CBD products under Radient’s platform to Canada and extend it to other international markets. Initially founded in the US, Dreamy has developed a lifestyle brand over the past decade focused on the Health and Wellness space before branching into the CBD vertical. Dreamy is focused on creating and inspiring people to use plant medicine and holistic healing in place of conventional pharmaceutical solutions. In the US, Dreamy CBD enjoys a strong presence in California, and the Dreamy brand has a strong association with a positive lifestyle in the rapidly growing Wellness space. The Dreamy CBD products comprise CBD tinctures, CBD distillates, CBD edibles, CBD cosmetics, and CBD Vape Cartridges geared towards the recreational and medical cannabis market. Under this partnership, Radient will have exclusive rights to the licenses and trademarks for Dreamy CBD brands and will collaborate jointly with Dreamy to produce their CBD products and launch their brands in Canada. Radient will be involved in providing the processing facilities in Edmonton and the necessary infrastructure to extract CBD products for Dreamy CBD. In addition, through its Sales License and associated registrations in the provinces, Radient will look to build the Dreamy CBD product portfolio in Canada. On the international front, Radient will produce their CBD based products for markets in Thailand and Japan that are witnessing a strong surge in CBD products consumption, especially in the Wellness space. This will be after completing a comprehensive review of the trade requirements with local partners in these jurisdictions. The partnership is being set initially for a two-year term with an annual renewable option, with Radient reserving the right of first refusal to acquire Dreamy.
Reported Earnings • Oct 10First quarter earnings releasedOver the last 12 months the company has reported total losses of CA$36.5m, with losses widening by 19% from the prior year. Total revenue was CA$18.4m over the last 12 months, up by CA$18.2m from the prior year.
공시 • Sep 19+ 1 more updateRadient Technologies Inc. Announces Management ChangesThe board of Radient Technologies Inc. named Jan Petzel as Interim President, effective immediately. Mr. Petzel has been a Director of the Radient since 2016 and has a comprehensive understanding of the company, and a pragmatic view of the priorities that need to be addressed. Jan was a managing director in the Merchant Banking Division of Goldman Sachs, ultimately responsible for private credit in Germany and Scandinavia. While at Goldman Sachs, Mr. Petzel served on the board of several successful companies including Cognis GmbH, a worldwide supplier of specialty chemicals and nutritional ingredients, up to its sale to BASF for €3.1 billion in 2010. The company also announced that Denis Taschuk will step down as president and director of the company, effectively immediately, for family reasons. He will continue as advisor to the Board to facilitate the transition to a new chief executive officer. Denis has been instrumental in leading Radient to become a significant company in the cannabis industry, and the Board wishes to thank Denis for his contribution and tireless efforts over the last 10 years. The company also announced that Mike Cabigon will step down as chief operating officer and director of the company, effective immediately, to pursue other interests. Mike was instrumental in the company’s pivot into the cannabis industry in 2016, and the Board thanks him for all his contribution over the years and wishes him well in his future endeavors.
공시 • Sep 17Radient Technologies Inc. Auditor Raises 'Going Concern' DoubtRadient Technologies Inc. filed its Annual on Sep 14, 2020 for the period ending Mar 31, 2020. In this report its auditor, Grant Thornton, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
